Nature's Sunshine Products, Inc. - Common Stock (NATR)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Apr 1, 2026Investment Snapshot
- Trading 68% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 14.6% — below-average profitability
- Revenue growing at 6% annually
Nature's Sunshine Products, Inc. - Common Stock (NATR) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $420 million . Key value metrics: P/E ratio 21.3, P/B ratio 2.91, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Nature's Sunshine Products, Inc. - Common Stock — Fundamental Analysis Summary
Nature's Sunshine Products, Inc. - Common Stock (NATR) is currently trading 68% above its Graham Number of $14.24, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 21.3x.
On financial health, NATR shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 14.6% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.02.
StockPik's composite Value Score for NATR is 82/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NATR reports a high gross margin of 72.1% (sector average: 33.5%) and a modest operating margin of 5.2%.
NATR shows revenue growing at 6% year-over-year, with earnings growing at 154%.